Skip to Content

AegirBio AB Ordinary Shares AEGIR

Morningstar Rating
SEK 0.73 +0.01 (1.24%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

AEGIR is trading at a 54% discount.
Price
SEK 0.73
Fair Value
SEK 8.67
Uncertainty
Extreme
1-Star Price
SEK 45.66
5-Star Price
SEK 7.74
Economic Moat
Zpkv
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AEGIR is a good fit for your portfolio.

Trading Information

Previous Close Price
SEK 0.72
Day Range
SEK 0.680.74
52-Week Range
SEK 0.503.59
Bid/Ask
SEK 0.69 / SEK 0.73
Market Cap
SEK 22.65 Mil
Volume/Avg
21,512 / 172,093

Key Statistics

Price/Earnings (Normalized)
0.07
Price/Sales
190.32
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

AegirBio AB is a Swedish diagnostic company that offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. The company's products include Monator - drug monitoring of tysabri in MS, Veritope, and Magniareader.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
15

Valuation

Metric
AEGIR
Price/Earnings (Normalized)
0.07
Price/Book Value
2.53
Price/Sales
190.32
Price/Cash Flow
Price/Earnings
AEGIR

Financial Strength

Metric
AEGIR
Quick Ratio
2.53
Current Ratio
2.53
Interest Coverage
−35.53
Quick Ratio
AEGIR

Profitability

Metric
AEGIR
Return on Assets (Normalized)
−61.72%
Return on Equity (Normalized)
−86.45%
Return on Invested Capital (Normalized)
−71.71%
Return on Assets
AEGIR
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesXtjxjfgJnckqr$197.2 Bil
SYK
Stryker CorpZttsvtfkhYmyhc$136.2 Bil
MDT
Medtronic PLCMknqbzqfLgllfck$115.7 Bil
BSX
Boston Scientific CorpGrxlcmphwRrrbgp$100.7 Bil
EW
Edwards Lifesciences CorpCffrnylxfjTzytxrc$57.5 Bil
DXCM
DexCom IncZxydmjlmQbtnb$53.5 Bil
ZBH
Zimmer Biomet Holdings IncYfhjlywzrXtgk$27.1 Bil
ALGN
Align Technology IncLdxlftbhXqbbpy$24.6 Bil
PHG
Koninklijke Philips NV ADRZqrxnwsyhJszkqjs$18.2 Bil
PODD
Insulet CorpGxmflzbvNdwtkwf$12.0 Bil

Sponsor Center